Post hoc analysis of CANVAS and CREDENCE (8614 participants with type 2 diabetes): abnormal urine leukocyte esterase or nitrite predicted UTI, but canagliflozin did not increase first UTI vs placebo (HR 1.07; 95% CI 0.93-1.22), and dipstick results did not modify this.
Secondary analysisn = 8,614
Doi et al. Urinary dipstick findings and UTI risk with SGLT2 inhibitors: a post-hoc analysis of the CANVAS and CREDENCE trials